Literature DB >> 8119351

Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.

R Coria-Jiménez1, C Ortiz-Torres.   

Abstract

Aminoglycoside resistance patterns of 147 Serratia marcescens strains of clinical origin were studied. All strains analysed belonged to three different bacterial populations. The periods of study and the institutions the strains were isolated from correlated significantly with the resistance patterns shown by the strains. The most frequent resistance patterns found were the following: ACC (6')-I at the Hospital Infantil de México (Children's Hospital of México), and ANT (2'') + AAC(6')-I at the Instituto Nacional de Pediatría (INPed or National Institute of Pediatrics) in Mexico City. Furthermore, the isolation frequency of aminoglycoside-sensitive strains decreased remarkably at the INPed over a 12-year period. These results suggest that there has been a selection of Serratia marcescens strains that are very resistant to aminoglycosides.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8119351      PMCID： PMC2271489          DOI： 10.1017/s0950268800057484

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  24 in total

1.  Biotyping of Serratia marcescens strains of clinical origin.

Authors:  R Coria-Jiménez; C Ortiz-Torres; R Cruz-Camarillo
Journal:  Rev Latinoam Microbiol       Date:  1992 Oct-Dec

2.  Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital.

Authors:  T A Larson; C R Garrett; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

3.  Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.

Authors:  C C Sanders; C Watanakunakorn
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

4.  [Development of resistance to aminoglycosides in hospital strains of Serratia].

Authors:  M C Mendoza; M G Blanco; F Javier Mendez; C Hardisson
Journal:  Pathol Biol (Paris)       Date:  1984-09

5.  In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.

Authors:  F W Goldstein; L Gutmann; R Williamson; E Collatz; J F Acar
Journal:  Ann Microbiol (Paris)       Date:  1983 May-Jun

6.  Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.

Authors:  C E Rubens; Z A McGee; W E Farrar
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

7.  Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.

Authors:  J Sifuentes-Osornio; G M Ruiz-Palacios; D H Gröschel
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

8.  Detection of Serratia outbreaks in hospital.

Authors:  J J Farmer; B R Davis; F W Hickman; D B Presley; G P Bodey; M Negut; R A Bobo
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

9.  Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.

Authors:  W H Traub; M Spohr; D Bauer
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

10.  Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States.

Authors:  K Shimizu; T Kumada; W C Hsieh; H Y Chung; Y Chong; R S Hare; G H Miller; F J Sabatelli; J Howard
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191
View more
  4 in total

1.  Postantibiotic effects of gentamicin and netilmicin on Serratia marcescens: effects on hydrophobicity and motility.

Authors:  L Majtánová; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit.

Authors:  G Miranda; C Kelly; F Solorzano; B Leanos; R Coria; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

3.  Proteolytic activity in Serratia marcescens clinical isolates.

Authors:  R Coria-Jiménez; C Zárate-Aquino; O Ponce-Ponce
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Effects of Bacillus Serine Proteases on the Bacterial Biofilms.

Authors:  Olga Mitrofanova; Ayslu Mardanova; Vladimir Evtugyn; Lydia Bogomolnaya; Margarita Sharipova
Journal:  Biomed Res Int       Date:  2017-08-21       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.